A study led by the Neuromuscular and Neuropediatric Research Group at the Germans Trias i Pujol Research Institute shows for the first time that carriers of McArdle's disease can also show symptoms.
At the IGTP TODAY
Rice against HIV: a three-protein cocktail produced in seeds shows potent HIV neutralization in vitro
Researchers from University of Lleida-Agrotecnio, IrsiCaixa AIDS Research Institute and ICREA obtained for the first time three different anti-HIV proteins from a single transgenic rice plant and crude extracts from it averted HIV from entering in human cells in vitro. Rice components showed an enhancing effect, further helping to block HIV infectivity. Dr Julià Blanco, researcher from the Institut Germans Trias i Pujol at IrsiCaixa, where he leads the Cell Virology and Immunology group, participated in the study.
In June this year the new Comparative Medicine and Bioimage Centre of Catalonia (CMCiB) started its normal working activities. Located at the highest point of the campus, the CMCiB is a centre promoted by the Germans Trias i Pujol Research Institute (IGTP) and dedicated to biomedical research and training. The centre is an important addition to scientific infrastructures in southern Europe and is the only one in Spain, it has been set up to become a reference in comparative medicine, bioimaging and computational models with a clear remit to promote alternative research models and methods
A paper published by the IGTP Kidney-affecting Research Group (REMAR) is in the top 100 most read cellular biology papers in Scientific Reports in 2017. The journal published around one thousand articles on cellular biology last year, making the ranking especially remarkable for this paper on which Dr Francesc Borràs is co-corresponding author. The paper is ranked at 54.
The IGTP has organized a morning with the charity Fundació Salut Alta from Badalona that got everybody sticking together! The result of the experiment was 55 balls of coloured slime and a lot of happy faces!
Since 2007 the Immunopathology Group led by Dr Eva Martínez-Cáceres and Dr Cristian Ramo Tello at the IGTP has been working to develop a new treatment for autoimmune diseases, in this case for multiple sclerosis. To help their work in this task, Dr Martinez Cáceres has coordinated a COST project, a European network of scientists working on similar problems; the project concluded in 2017 and has now published its scientific report.
The Innovation in Respiratory Infections and Tuberculosis Diagnosis Group at the IGTP is partnering with Mind the Byte to work on the characterization and binding analysis of an immunostimulant known to trigger T-cell activation, which is crucial for the initiation and regulation of the immune response.
A study reveals the presence of proteins from hypnozoites, the latent phase of the parasite, in circulating extracellular vesicles. Proteins derived from the latent liver stage of Plasmodium vivax can be detected in small extracellular vesicles that circulate in blood, according to a study led by Hernando del Portillo, ICREA Research Professor at the IGTP and ISGlobal. The results pave the way for identifying patients with asymptomatic infections, an essential requirement to stop parasite transmission.
The Neurogenetics Research Group at the Germans Trias i Pujol Research Group, led by Dr Antoni Matilla has found the mutation and described the molecular mechanism that causes the sub-type of ataxia SCA37, which they first described in 2013. This find means that all the families with this alteration can be diagnosed before symptoms appear and that carriers can receive genetic counselling. It is also the first step on developing personalized therapies.
The DiabetesCero (Diabetes Zero) Foundation has got the European Parliament talking about Diabetes Type 1
From Vilanova i la Geltrú to Brussels by bicycle. This challenge was accepted by the father of a boy with diabetes type 1 (DT1) and member of the charity DiabetesCero, and on the way he managed get Euro MPs interested in the disease. His amazing journey has produced a meeting to discuss the DT1 on 21-22 June; Dr Marta Vives-Pi, Group Leader of the Immunology of Diabetes Group of the IGTP was there.